Skip to main content
Data show positive results for Insulet's Omnipod in children

Data show use of Insulet's tubeless, closed-loop Omnipod insulin management system for two to three days in children aged 2 to 6 with type 1 diabetes led to 32% more time spent in range over 24 hours and 47% more time in range with low glucose levels overnight. The patients received treatment with the device following a week of standard therapy and exercised for over half an hour daily.

Full Story: